dndn怎么了？

buctusa

DNDN = Da Niu Da Niu

名字没有取好。
DNDN = DowNDowN
CoolMax 发表于 2009-4-28 13:35

summer123

INSIDER TRANSACTIONS REPORTED - LAST TWO YEARS
Date                        Insider                               Shares        Type        Transaction        Value*
20-Apr-09        COX GREG Officer              15,313        Direct        Option Exercise at $4.30 - $20 per share.        N/A
20-Apr-09        COX GREG Officer              17,481        Direct        Sale at $20 per share.        $349,620
14-Apr-09        CANET GERARDO Director        109,171        Direct        Option Exercise at $4.41 - $13.56 per share.        N/A
14-Apr-09        CANET GERARD Director        109,171        Direct        Sale at $21.40 per share.        $2,336,259

xxtrader

估计消息不会差的话，估计再开盘就30以上了

qiangge

名字没有取好。
DNDN = DowNDowN
CoolMax 发表于 2009-4-28 13:35

xiaobailong

这个需要消息快，还要手快，缺一不可啊。现在咱们在消息面已经落后很多了，就算消息面不差，自问一下，自己操作是不是够快？

hotday

PROVENGE extended median survival by 4.1 months compared to placebo (25.8 months versus 21.7 months);

I don't see much difference, which means if you want to save money, use the "placebo" outright.

I bet in later stage patients, you only need to give blood transfusion to prolong that much life span.

QSCNC

I don't think will have any good news.

xiaobailong

PROVENGE extended median survival by 4.1 months compared to placebo (25.8 months versus 21.7 months);

I don't see much difference, which means if you want to save money, use the "placebo" outright ...
hotday 发表于 2009-4-28 14:07

xxtrader

其实就是一个延长生命的百分比，如果超过22。5％就会涨，不会低过，因为22.5％是达标，已经公布过达标所以7块多飞到25，今天就是赌这个百分比，楼上的你们搞那么复杂干嘛。研究就要研究重点，晕死了。。

QuickHand

药股和生化股操纵很严重...

xxtrader

药股和生化股操纵很严重...
QuickHand 发表于 2009-4-28 14:12

这个是癌症的未来
不是操纵的问题，很多BIOTECH专家大拿说，DNDN是BIOTECH的BLUE CHIP，如果这个疫苗进入市场销售，DNDN2－3年后的股票价格必然过150

summer123

Cancer
Data Shows Provenge Extends Cancer Survival
Matthew Herper, 04.28.09, 02:01 PM EDT
Dendreon released some data on its prostate cancer drug, Provenge.

CHICAGO -- Dendreon released some data related to its prostate cancer drug Provenge ahead of a data presentation here at the American Urological Association.

The data show that Provenge, the company's immunotherapy for prostate cancer, extended survival in a clinical trial by a median 4.1 months, reducing the risk of death by 22.5% in a 500-person study.

The result is unlikely to be due to chance. Its statistical p-value is 0.032, meaning roughly that there is only a three in 100 chance the result happened randomly. Scientists generally assume results with a p value of less than one in 100 are trustworthy.

A press release from the AUA also states that the number of patients who are alive three years after treatment is 38% greater among those who received Provenge.

That's surprising, says Donald Berry, a statistician at M.D. Anderson Cancer Center. Normally a 38% difference, in 500 patients, would have resulted in a much greater level of statistical significance. "Deaths occurring after three years are the most likely reason for the marginal level of statistical significance," Berry says.

Otis Brawley, chief medical officer of the American Cancer Society, says that he is "encouraged" by the data but warns, "I still think we need to be cautious."

"Please keep in mind, at best this is an effective treatment, it is not a cure for metastatic prostate cancer," says Brawley. "It may very well be an important new therapy. It is important that the scientific community digest this and do it right."

sinnet

PROVENGE extended median survival by 4.1 months compared to placebo (25.8 months versus 21.7 months);

I don't see much difference, which means if you want to save money, use the "placebo" outright ...
hotday 发表于 2009-4-28 14:07

By comparison, Taxotere, the only chemotherapy approved for men in late stage prostate cancer, only increases 3 months.
So this drug by far is the best on the market.

Of course you can choose placebo. You can choose to die earlier, who cares anyway.

ctcld

poor longs

xxtrader

这个结果应该还算不错吧。
xiaobailong 发表于 2009-4-28 14:20

这个是狠牛的生物科技股票，在俺满仓的BIOTECH股票里是属于风险最小的一个了。怕什么啊，老大

summer123

35# xxtrader


Would you give list of Biotech stocks? Thnaks.

xiaobailong

这个是狠牛的生物科技股票，在俺满仓的BIOTECH股票里是属于风险最小的一个了。怕什么啊，老大
xxtrader 发表于 2009-4-28 14:22

我不怕啊，我没有这方面的股票。没long也没short, 只是看看。

Mushroom

这怎么看着很像是在赌博

ctcld

wu long?

Time Market Status
15:05:01 ET NASDAQ NASDAQ has reviewed the transactions under rule 11890 (b) on its own motion filing involving the security Dendreon Corp. (DNDN) executed between 13:25:00 and 13:27:02 ET today and has determined that all trades will stand. This decision cannot be appealed. NASDAQ MarketWatch has coordinated this decision with other UTP Exchanges.
NEW - Clearly Erroneous Viewer Enhancements!

ByStander

名字没有取好。
DNDN = DowNDowN
CoolMax 发表于 2009-4-28 13:35